Emerging horizons in cancer therapy: Squamous transition drives drug resistance
Ningxia Zhang , Xinyuan Tong , Hongbin Ji
Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (6) : e1697
Emerging horizons in cancer therapy: Squamous transition drives drug resistance
• Adeno-to-squamous transition (AST) drives targeted therapy resistance. • Progressive plasticity is acquired during Adeno-to-squamous transition (AST).
Adeno-to-squamous transition (AST) / Drug Resistance / Targeted Therapy
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
2024 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.
/
| 〈 |
|
〉 |